Furthermore, IGF2BP2 is linked to tumor growth and poor outcome in other cancer types, such as HCC [15, 19], gallbladder cancer [20], pancreatic cancer [21], and glioblastoma [22–24]. This evidence concerns the gene IGF2BP2 and neoplasm.